Literature DB >> 11254757

GPI-specific phospholipase D associates with an apoA-I- and apoA-IV-containing complex.

M A Deeg1, E L Bierman, M C Cheung.   

Abstract

Glycosylphosphatidylinositol-specific phospholipase D (GPI-PLD) is abundant in serum and associates with high density lipoproteins (HDL). We have characterized the distribution of GPI-PLD among lipoproteins in human plasma. Apolipoprotein (apo)-specific lipoproteins containing apoB (Lp[B]), apoA-I and A-II (Lp[A-I, A-II]), or apoA-I only (Lp[A-I]) were isolated using dextran sulfate and immunoaffinity chromatography. In six human plasma samples with HDL cholesterol ranging from 39 to 129 mg/dl, 79 +/- 14% (mean +/- SD) of the total plasma GPI-PLD activity was associated with Lp[A-I], 9 +/- 12% with Lp[A-I, A-II], and 1 +/- 1% with Lp[B]; and 11 +/- 10% was present in plasma devoid of these lipoproteins. Further characterization of the GPI-PLD-containing lipoproteins by gel-filtration chromatography and nondenaturing polyacrylamide and agarose gel electrophoresis revealed that these apoA-I-containing particles/complexes were small (8 nm) and migrated with pre-beta particles on agarose electrophoresis. Immunoprecipitation of GPI-PLD with a monoclonal antibody to GPI-PLD co-precipitated apoA-I and apoA-IV but little or no apoA-II, apoC-II, apoC-III, apoD, or apoE. In vitro, apoA-I but not apoA-IV or bovine serum albumin interacted directly with GPI-PLD, but did not stimulate GPI-PLD-mediated cleavage of a cell surface GPI-anchored protein. Thus, the majority of plasma GPI-PLD appears to be specifically associated with a small, discrete, and minor fraction of lipoproteins containing apoA-I and apoA-IV. -- Deeg, M. A., E. L. Bierman, and M. C. Cheung. GPI-specific phospholipase D associates with an apoA-I- and apoA-IV-containing complex. J. Lipid Res. 2001. 42: 442--451.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11254757

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  8 in total

Review 1.  Molecular mechanisms involved in NAFLD progression.

Authors:  Mariano Malaguarnera; Michelino Di Rosa; Ferdinando Nicoletti; Lucia Malaguarnera
Journal:  J Mol Med (Berl)       Date:  2009-04-08       Impact factor: 4.599

2.  Structure-function relationships of HDL in diabetes and coronary heart disease.

Authors:  Mathias Cardner; Mustafa Yalcinkaya; Sandra Goetze; Edlira Luca; Miroslav Balaz; Monika Hunjadi; Johannes Hartung; Andrej Shemet; Nicolle Kränkel; Silvija Radosavljevic; Michaela Keel; Alaa Othman; Gergely Karsai; Thorsten Hornemann; Manfred Claassen; Gerhard Liebisch; Erick Carreira; Andreas Ritsch; Ulf Landmesser; Jan Krützfeldt; Christian Wolfrum; Bernd Wollscheid; Niko Beerenwinkel; Lucia Rohrer; Arnold von Eckardstein
Journal:  JCI Insight       Date:  2020-01-16

3.  Impact of genetic deletion of platform apolipoproteins on the size distribution of the murine lipoproteome.

Authors:  Scott M Gordon; Hailong Li; Xiaoting Zhu; Patrick Tso; Catherine A Reardon; Amy S Shah; L Jason Lu; W Sean Davidson
Journal:  J Proteomics       Date:  2016-07-03       Impact factor: 4.044

4.  Plasma glycosylphosphatidylinositol-specific phospholipase D predicts the change in insulin sensitivity in response to a low-fat but not a low-carbohydrate diet in obese women.

Authors:  Dona L Gray; Kevin D O'Brien; David A D'Alessio; Bonnie J Brehm; Mark A Deeg
Journal:  Metabolism       Date:  2008-04       Impact factor: 8.694

5.  Phosphatidylinositol-glycan-phospholipase D is involved in neurodegeneration in prion disease.

Authors:  Jae-Kwang Jin; Byungki Jang; Hyoung Tae Jin; Eun-Kyoung Choi; Cha-Gyun Jung; Hiroyasu Akatsu; Jae-Il Kim; Richard I Carp; Yong-Sun Kim
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

6.  Galectin 3-binding protein suppresses amyloid-β production by modulating β-cleavage of amyloid precursor protein.

Authors:  Tsuneyoshi Seki; Motoi Kanagawa; Kazuhiro Kobayashi; Hisatomo Kowa; Naoki Yahata; Kei Maruyama; Nobuhisa Iwata; Haruhisa Inoue; Tatsushi Toda
Journal:  J Biol Chem       Date:  2020-01-29       Impact factor: 5.157

7.  Insulin-mimicking bioactivities of acylated inositol glycans in several mouse models of diabetes with or without obesity.

Authors:  Susumu Suzuki; Chitose Suzuki; Yoshinori Hinokio; Yasushi Ishigaki; Hideki Katagiri; Makoto Kanzaki; Viatcheslav N Azev; Nilanjana Chakraborty; Marc d'Alarcao
Journal:  PLoS One       Date:  2014-06-27       Impact factor: 3.240

8.  Interaction of Full-Length Glycosylphosphatidylinositol-Anchored Proteins with Serum Proteins and Their Translocation to Cells In Vitro Depend on the (Pre-)Diabetic State in Rats and Humans.

Authors:  Günter A Müller; Andreas Lechner; Matthias H Tschöp; Timo D Müller
Journal:  Biomedicines       Date:  2021-03-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.